RuxolitinibVarious toxicities following off-label use: 5 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1965卷 / 1期

关键词：

D O I：

10.1007/s40278-023-43401-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：433 / 433

相关论文

共 50 条

[41] TocilizumabVarious toxicities following an off-label use: 3 case reports
Reactions Weekly, 2020, 1820 (1) : 293 - 293
[42] CabozantinibVarious toxicities following off-label use: 4 case reports
Reactions Weekly, 2020, 1810 (1) : 61 - 61
[43] BaricitinibVarious toxicities following off-label use: 4 case reports
Reactions Weekly, 2022, 1933 (1) : 111 - 111
[44] AdalimumabVarious toxicities following off-label use: 4 case reports
Reactions Weekly, 2018, 1718 (1) : 14 - 14
[45] DexmedetomidineVarious toxicities following off-label use: 4 case reports
Reactions Weekly, 2020, 1786 (1) : 75 - 75
[46] AnakinraVarious toxicities following off-label use: 16 case reports
Reactions Weekly, 2015, 1546 (1) : 25 - 25
[47] DiminazeneVarious toxicities following off-label use: 4 case reports
Reactions Weekly, 2023, 1984 (1) : 201 - 201
[48] AtropineVarious toxicities following off-label use: 2 case reports
Reactions Weekly, 2019, 1766 (1) : 66 - 66
[49] Ciclosporin/ruxolitinibVarious toxicities, lack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1889 (1) : 111 - 111
[50] VidarabineVarious toxicities following off-label use of vidarabine in paediatric patients : 5 case reports
Reactions Weekly, 2020, 1813 (1) : 227 - 227

← 1 2 3 4 5 →